Laser enucleation of the prostate for benign prostatic hyperplasia

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00008206

Enrollment

Registered

2015-05-07

Start date

2015-03-25

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

N40

Interventions

Group 1: Enucleation with Holmium laser Group 2: Enucleation with Thulium laser

Eligibility

Sex/Gender

Male

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: • IPSS-Score = 12 • Uroflowmetrie Qmax = 15ml/s • male patient =18 years and/or ineffective medical therapy of BPO, history of recurrent urinary tract infections, bladder stones, history of recurrent urinary retention, postrenal failure due to BPO

Exclusion criteria

Exclusion criteria: • prevoius surgery of urinary tract/prostate • known urrethral stricture • known prostate cancer • neurogenic disorder of bladder function • not willing to take part in the study

Design outcomes

Primary

Measure	Time frame
objective reduction of miciton parameters (international prostate symptom score (IPSS), Qmax) after 1, 6, 12, 24 months	—

Secondary

Measure	Time frame
collection of intra and postoperative complications	—

Countries

Germany

Contacts

Public ContactChristopher Netsch

Asklepios Klinik Barmbek

urologie.barmbek@asklepios.com0049 40 1818 829821

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026